Invention Grant
- Patent Title: 5,5-bicyclic oxazole orexin receptor antagonists
-
Application No.: US15529688Application Date: 2015-12-14
-
Publication No.: US09987255B2Publication Date: 2018-06-05
- Inventor: Scott D. Kuduk , Nigel Liverton , Thomas S. Reger , Jason W. Skudlarek
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent J. Eric Thies; John C. Todaro
- International Application: PCT/US2015/065457 WO 20151214
- International Announcement: WO2016/100162 WO 20160623
- Main IPC: A61K31/422
- IPC: A61K31/422 ; C07D487/04 ; A61K31/407 ; C07D263/30
Abstract:
The present invention is directed to 5,5-bicyclic oxazole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.
Public/Granted literature
- US20170368035A1 5,5-Bicyclic Oxazole Orexin Receptor Antagonists Public/Granted day:2017-12-28
Information query
IPC分类:
